CD274 and melanoma: On the other hand, pharmacological inhibition of PAI1 with tiplaxtinin could block lysosomal degradation to up-regulate surface PDL1 expression in melanoma to synergize PDL1 immune checkpoint blockade [17], which indicates that PAI1-mediated endocytosis is a novel mechanism to regulate the homeostasis of signal molecules.